SINGH MOLECULAR MEDICINE LLC has a total of 13 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, Australia and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are SINGH BIOTECHNOLOGY LLC, ECS PROGASTRIN SA and BIOND BIOLOGICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Australia | 3 | |
#3 | Republic of Korea | 2 | |
#4 | Canada | 1 | |
#5 | Hungary | 1 | |
#6 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Analysing materials | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Measuring microorganism processes | |
#6 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Singh Sunanda | 13 |
Publication | Filing date | Title |
---|---|---|
US2017267784A1 | Single domain antibodies directed against intracellular antigens | |
HUE047601T2 | Single domain antibodies directed against intracellular antigens |